학술논문

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Document Type
Article
Source
In Blood Advances October 2022
Subject
Lymphoid Neoplasia
Health Services and Outcomes
Language
ISSN
2473-9529